A gene has been discovered that can naturally suppress the signs of Alzheimer’s Disease in human brain cells, in research led by Queen Mary University of London. The scientists have also developed a new rapid drug-screening system for treatments that could potentially delay or prevent the disease. The main challenge in testing Alzheimer’s drugs in […]
Scientists are a step closer to understanding which genes are responsible for early onset Alzheimer’s disease in people with Down’s syndrome
A new study from researchers at King’s Health Partners and South London and the Maudsley Foundation NHS trust shows that people with Down’s syndrome who develop dementia can benefit from drugs commonly used to treat the condition. The work, led by Professor André Strydom (King’s College London) and published online this week in the British […]
On 19 September our Services Development Manager, Julian Hallett, attended a very interesting conference in London hosted by The Dementia Action Alliance. The Alliance is a network of organisations, partly funded by Public Health England, whose aim is to connect, share best practice and take action on dementia. They currently have a focus on improving […]
Saturday 17 September | 3.00 – 5.00pm | Cambridge
On Sunday 26 July, a team of researchers from Cambridge University came to the Langdon Down Centre to talk about their research: Defeat Dementia in Down’s Syndrome. They have a number of really exciting studies that they wanted to share. Sally, Maddie, Liam, Francesco, Alexandra and Tony were available to talk to our visitors about […]
With the support of the Down’s Syndrome Association, and with funding from the Medical Research Council (MRC), we have been working together with people with Down’s syndrome and their families and support workers to find out what causes dementia (Alzheimer’s disease), an illness that can affect people with Down’s syndrome at a relatively young age. […]
